Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02030106 · ClinicalTrials.gov registry record
Motherhood and Microbiome
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT02030106: Completed study, sponsored by University of Pennsylvania.
NCT02030106 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02030106 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
This is a prospective cohort, enriched with women with a prior term birth, of singleton pregnancies who will be followed for the outcome of preterm birth. The main exposure of interest is the characterization of the cervico-vaginal microbiota. Women will be recruited from a population seeking routine obstetrical care at obstetrical practices at Penn. They will have three research visits during pregnancy to complete questionnaires and collect samples of cervico-vaginal fluid and cervical cells. Outcome data will be collected about the prenatal events and timing of delivery.
Primary Outcome
Cervicovaginal Microbiota in Women With and Without Preterm Birth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-06-01 |
What the finished NCT02030106 record still lists
NCT02030106 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02030106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02030106 about?
NCT02030106 is a clinical study titled "Motherhood and Microbiome". This is a prospective cohort, enriched with women with a prior term birth, of singleton pregnancies who will be followed for the outcome of preterm birth. The main exposure of interest is the characterization of the cervico-vaginal microbiota. Women will be recruited from a population seeking routin...
What is the current status of trial NCT02030106?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2013-10. Estimated completion is 2017-06-01.
Who is sponsoring clinical trial NCT02030106?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia